Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 1
2004 1
2005 1
2006 3
2007 1
2008 1
2011 2
2012 2
2014 1
2015 4
2016 4
2017 8
2018 7
2019 3
2020 4
2021 4
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial.
Ponsioen CY, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Bossuyt PMM, Hart A, Warusavitarne J, Buskens CJ, van Bodegraven AA, Brink MA, Consten ECJ, van Wagensveld BA, Rijk MCM, Crolla RMPH, Noomen CG, Houdijk APJ, Mallant RC, Boom M, Marsman WA, Stockmann HB, Mol B, de Groof AJ, Stokkers PC, D'Haens GR, Bemelman WA; LIR!C study group. Ponsioen CY, et al. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):785-792. doi: 10.1016/S2468-1253(17)30248-0. Epub 2017 Aug 31. Lancet Gastroenterol Hepatol. 2017. PMID: 28838644 Clinical Trial.
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial.
Stevens TW, Haasnoot ML, D'Haens GR, Buskens CJ, de Groof EJ, Eshuis EJ, Gardenbroek TJ, Mol B, Stokkers PCF, Bemelman WA, Ponsioen CY; LIR!C study group. Stevens TW, et al. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):900-907. doi: 10.1016/S2468-1253(20)30117-5. Epub 2020 Jun 30. Lancet Gastroenterol Hepatol. 2020. PMID: 32619413 Clinical Trial.
IBD and genetics: new developments.
Oostenbrug LE, van Dullemen HM, te Meerman GJ, Jansen PL. Oostenbrug LE, et al. Scand J Gastroenterol Suppl. 2003;(239):63-8. doi: 10.1080/00855920310002717. Scand J Gastroenterol Suppl. 2003. PMID: 14743885 Review.
Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon.
Valkema MJ, Spaander MCW, Boonstra JJ, van Dieren JM, Hazen WL, Erkelens GW, Holster IL, van der Linden A, van der Linde K, Oostenbrug LE, Quispel R, Schoon EJ, Siersema PD, Doukas M, Eyck BM, van der Wilk BJ, van der Sluis PC, Wijnhoven BPL, Lagarde SM, van Lanschot JJB. Valkema MJ, et al. Among authors: oostenbrug le. Br J Surg. 2023 Sep 6;110(10):1381-1386. doi: 10.1093/bjs/znad211. Br J Surg. 2023. PMID: 37418342 Free PMC article.
Cohort Profile: The Inflammatory Bowel Disease South Limburg Cohort (IBDSL).
van den Heuvel TR, Jonkers DM, Jeuring SF, Romberg-Camps MJ, Oostenbrug LE, Zeegers MP, Masclee AA, Pierik MJ. van den Heuvel TR, et al. Among authors: oostenbrug le. Int J Epidemiol. 2017 Apr 1;46(2):e7. doi: 10.1093/ije/dyv088. Int J Epidemiol. 2017. PMID: 26045509 No abstract available.
Bite-on-bite biopsies for the detection of residual esophageal cancer after neoadjuvant chemoradiotherapy.
van der Bogt RD, van der Wilk BJ, Oudijk L, Schoon EJ, van Lijnschoten G, Corporaal S, Nieken J, Siersema PD, Bisseling TM, van der Post RS, Quispel R, van Tilburg A, Oostenbrug LE, Riedl RG, Hol L, Kliffen M, Nikkessen S, Eyck BM, van Lanschot JJB, Doukas M, Spaander MCW. van der Bogt RD, et al. Among authors: oostenbrug le. Endoscopy. 2022 Dec;54(12):1131-1138. doi: 10.1055/a-1846-1025. Epub 2022 Jun 3. Endoscopy. 2022. PMID: 35668664 Clinical Trial.
Classic drugs in the time of new drugs: real-world, long-term outcomes of thiopurine monotherapy in 1016 patients with inflammatory bowel disease.
Rezazadeh Ardabili A, Jeuring S, Mujagic Z, Oostenbrug L, Romberg-Camps M, Jonkers D, van Bodegraven A, Pierik M. Rezazadeh Ardabili A, et al. Among authors: oostenbrug l. Aliment Pharmacol Ther. 2022 Sep;56(6):1030-1043. doi: 10.1111/apt.17128. Epub 2022 Jul 6. Aliment Pharmacol Ther. 2022. PMID: 35794735 Free PMC article.
Predictive value of endoscopic esophageal findings for residual esophageal cancer after neoadjuvant chemoradiotherapy.
van der Bogt RD, van der Wilk BJ, Nikkessen S, Krishnadath KK, Schoon EJ, Oostenbrug LE, Siersema PD, Vleggaar FP, Doukas M, van Lanschot JJB, Spaander MCW. van der Bogt RD, et al. Among authors: oostenbrug le. Endoscopy. 2021 Nov;53(11):1098-1104. doi: 10.1055/a-1362-9375. Epub 2021 Mar 2. Endoscopy. 2021. PMID: 33652496 Clinical Trial.
48 results